ArticleMedicine2026
Tiopronin-induced reversible bilateral parotid gland enlargement in a patient with alcoholic cirrhosis: Case report.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
rationaleDrug-induced parotid gland enlargement is uncommon, and reports associated with tiopronin are extremely rare in both domestic and international literature. The mechanism remains unclear, and its rapid onset may easily lead to misdiagnosis as allergic reactions or other salivary gland diseases. Timely recognition and management are crucial to avoid unnecessary interventions. PATIENT CONCERNS: A 63-year-old man with alcoholic cirrhosis was admitted to our department for further management. Tiopronin was administered intravenously for hepatoprotective purposes. Approximately 20 minutes after the initiation of the infusion, the patient developed painless bilateral parotid gland swelling. DIAGNOSES: Emergency drug withdrawal was carried out immediately, and an ultrasound examination demonstrated bilateral parotid gland enlargement without obvious inflammatory changes or ductal dilation, consistent with acute noninflammatory sialadenosis.
interventionsThe tiopronin infusion was discontinued promptly. No additional interventions were administered. The patient was monitored closely with serial physical examinations. OUTCOMES: During the evening ward round on the same day, a significant reduction in parotid swelling was observed. Two days later, bilateral parotid gland enlargement had nearly completely resolved without specific treatment. LESSONS: Tiopronin-induced acute parotid gland enlargement is extremely rare. This case highlights the importance of considering drug-induced sialadenosis as a differential diagnosis when acute parotid swelling occurs shortly after drug administration. Early identification and discontinuation of the suspected agent can lead to rapid resolution, avoiding unnecessary interventions. Clinicians should be aware of this potential reaction and strengthen pharmacovigilance during tiopronin use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.